Aurobindo Pharma PAT drops to Rs 696.99 cr in Q2FY22
The Board of Directors of Aurobindo Pharma have approved the unaudited consolidated financial results of the company for the period ended September 30, 2021
The Board of Directors of Aurobindo Pharma have approved the unaudited consolidated financial results of the company for the period ended September 30, 2021
Bioanalytical approach to accelerate development efforts in the identification of compounds that can treat chlorine or sulfur mustard injuries
A Sanofi R&D executive will join the Gyroscope Clinical Advisory Board to advise on matters related to the development of GT005 for geographic atrophy (GA).
The Lucent 3D Lumbar Interbody System features a functionally unique multi-component device manufactured in a 3D printing sequence
The company has operations in North America, Asia, and Europe,
Divi's Laboratories Limited has reported consolidated financial results for the period ended September 30, 2021.
It is the world’s first DNA-based Covid vaccine
In the overall study population through Day 28, no deaths were reported in patients who received Paxlovid as compared to 10 deaths in patients who received placebo
The drug helps in managing cholesterol
The solution helps the pharma enterprises drive efficiencies, save costs, and increase productivity
Subscribe To Our Newsletter & Stay Updated